MILWAUKIE, Ore. — The American Association of Homeopathic Pharmacists (AAHP), representing the major manufacturers and distributors of homeopathic drugs, confirms that it is unaware of any homeopathic literature or clinical trial that specifically support the use of any homeopathic drug for prevention or treatment on the emerging 2019 Novel Coronavirus readm more…

Read More

AAHP is preparing comments to “FDA Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry.” Initially published in December 2017, the guidance was revised and republished in October 2019. FDA has now extended the comment period to March 23. AAHP victoriously requested that key elements of the 1988 readm more…

Read More

Since 2015, the Food and Drug Administration (FDA) has been engaged in a reevaluation of Compliance Policy Guide 400.400, Conditions under Which Homeopathic Drugs May Be Marketed. FDA issued a new draft policy in December 2017, and, after a public comment period, it issued a revised draft in October 2019, readm more…

Read More

Adopted August 22, 2012 Revised August 29, 2017 Introduction Homeopathic medicines play an increasing role in self-medication among American consumers. Homeopathic products sold at retail provide consumers with access to low cost, safe medications, and they are routinely marketed to consumers on retail shelves among other well known OTC products. readm more…

Read More

 Milwaukie, Ore., Autumn 2015—As the public debate on vaccinations rises, more healthcare providers and parents alike seek information. The American Association Homeopathic Pharmacists (AAHP) reminds manufacturers and marketers that the promotion of any product—homeopathic or otherwise—as an over-the-counter alternative to a vaccine is a violation of federal and state law. Furthermore, in readm more…

Read More

Washington, D.C., Sept. 22, 2015—Trade association leaders, experts in consumer marketing and regulations, and top physicians came together on Monday, September 21 in Washington, D.C. at “Homeopathic Medicine & Advertising: A Federal Trade Commission (FTC) Workshop.” President of the American Association of Homeopathic Pharmacists (AAHP) Mark Land stated, “We have readm more…

Read More

Industry leaders provide perspective on partnership opportunities for Federal Trade Commission Washington, D.C., Sept. 21, 2015— To better help consumers make informed choices, the American Association of Homeopathic Pharmacists (AAHP) proposed strengthening product label and advertising disclosures to the Federal Trade Commission (FTC) today in Washington, D.C. at the agency’s readm more…

Read More

The American Association of Homeopathic Pharmacists (AAHP), representing the principal manufacturers and distributors of homeopathic medicines in the United States, said today it fully supports the Food and Drug Administration’s position that consumers should seek the advice of their health care provider if they suspect they or their children are readm more…

Read More

National Health and Medical Research Council (NHMRC) Information Paper: Evidence on the effectiveness of homeopathy for treating health conditions On March 11, 2015, the Australian National Health and Medical Research Council (NHMRC) released an information paper and announcement regarding evidence on the effectiveness of homeopathy for treating health conditions. The readm more…

Read More

While the causal relationship between intranasal zinc preparations and anosmia is examined in a study published in the July 2010 issue of Archives of Otolaryngology-Head & Neck Surgery, the study’s practical application on public health is reduced to supporting action taken the following summer by the U.S. Food and Drug Administration (FDA) in removing related products from the marketplace.

Read More